Factors associated with pityriasis versicolor in a large national database.
All of Us
acne
age
female
hypothyroidism
pityriasis versicolor
sex
tinea versicolor
type 2 diabetes mellitus
Journal
Mycoses
ISSN: 1439-0507
Titre abrégé: Mycoses
Pays: Germany
ID NLM: 8805008
Informations de publication
Date de publication:
Aug 2024
Aug 2024
Historique:
revised:
11
07
2024
received:
29
05
2024
accepted:
18
07
2024
medline:
31
7
2024
pubmed:
31
7
2024
entrez:
30
7
2024
Statut:
ppublish
Résumé
Pityriasis versicolor (PV), a cutaneous fungal infection, most commonly affects adolescents and young adults and is associated with hyperhidrosis and humid weather. Understanding other factors associated with PV might help improve diagnostic and treatment practices. PV's associations with patient demographics, comorbidities and medication exposures were assessed using the All of Us Database, a large, diverse, national database from the United States. A case-control study with multivariable analysis was performed. We identified 456 PV case-patients and 1368 control-patients. PV case-patients (vs. control-patients) were younger (median age [years] (standard deviation): 48.7 (15.4) vs. 61.9 (15.5); OR: 0.95, CI: 0.94-0.96) and more likely to be men versus women (42.8% vs. 33.9%, OR: 1.45, CI: 1.16-1.79) and Black (19.5% vs. 15.8%, OR: 1.35, 95% CI: 1.02-1.80) or Asian (4.6% vs. 2.7%, OR: 1.86, CI: 1.07-3.24) versus White. PV case-patients more frequently had acne (5.3% vs. ≤1.5%, OR: 5.37, CI: 2.76-10.48) and less frequently had type 2 diabetes mellitus (T2DM) (14.7% vs. 24.7%, OR: 0.52, CI: 0.39-0.70) and hypothyroidism (OR: 10.3% vs. 16.4%, OR: 0.59, CI: 0.42-0.82). In multivariable analysis, PV odds were significantly higher in those with acne and lower in those with T2DM, older age and female sex. Our results may be used as a basis for future studies evaluating whether acne treatment may decrease PV risk. Physicians could educate patients with acne about PV, including strategies to control modifiable PV risk factors, such as avoidance of hot and humid environments and avoidance of use of topical skin oils.
Sections du résumé
BACKGROUND
BACKGROUND
Pityriasis versicolor (PV), a cutaneous fungal infection, most commonly affects adolescents and young adults and is associated with hyperhidrosis and humid weather. Understanding other factors associated with PV might help improve diagnostic and treatment practices.
OBJECTIVES
OBJECTIVE
PV's associations with patient demographics, comorbidities and medication exposures were assessed using the All of Us Database, a large, diverse, national database from the United States.
METHODS
METHODS
A case-control study with multivariable analysis was performed.
RESULTS
RESULTS
We identified 456 PV case-patients and 1368 control-patients. PV case-patients (vs. control-patients) were younger (median age [years] (standard deviation): 48.7 (15.4) vs. 61.9 (15.5); OR: 0.95, CI: 0.94-0.96) and more likely to be men versus women (42.8% vs. 33.9%, OR: 1.45, CI: 1.16-1.79) and Black (19.5% vs. 15.8%, OR: 1.35, 95% CI: 1.02-1.80) or Asian (4.6% vs. 2.7%, OR: 1.86, CI: 1.07-3.24) versus White. PV case-patients more frequently had acne (5.3% vs. ≤1.5%, OR: 5.37, CI: 2.76-10.48) and less frequently had type 2 diabetes mellitus (T2DM) (14.7% vs. 24.7%, OR: 0.52, CI: 0.39-0.70) and hypothyroidism (OR: 10.3% vs. 16.4%, OR: 0.59, CI: 0.42-0.82). In multivariable analysis, PV odds were significantly higher in those with acne and lower in those with T2DM, older age and female sex.
CONCLUSIONS
CONCLUSIONS
Our results may be used as a basis for future studies evaluating whether acne treatment may decrease PV risk. Physicians could educate patients with acne about PV, including strategies to control modifiable PV risk factors, such as avoidance of hot and humid environments and avoidance of use of topical skin oils.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13775Informations de copyright
© 2024 Wiley‐VCH GmbH. Published by John Wiley & Sons Ltd.
Références
Salahi‐Moghaddam A, Davoodian P, Jafari A, Nikoo MA. Evaluation of pityriasis versicolor in prisoners: a cross‐sectional study. Indian J Dermatol Venereol Leprol. 2009;75(4):379‐382. doi:10.4103/0378-6323.53134
Hudson A, Sturgeon A, Peiris A. Tinea versicolor. JAMA. 2018;320(13):1396. doi:10.1001/jama.2018.12429
Leung AK, Barankin B, Lam JM, Leong KF, Hon KL. Tinea versicolor: an updated review. Drugs Context. 2022;11:2022‐9‐2. doi:10.7573/dic.2022-9-2
Yadgar RJ, Bhatia N, Friedman A. Cutaneous fungal infections are commonly misdiagnosed: a survey‐based study. J Am Acad Dermatol. 2017;76(3):562‐563. doi:10.1016/j.jaad.2016.09.041
Caplan AS, Caturvedi S, Zhu Y, et al. Notes from the field: first reported U.S. cases of tinea caused by Trichophyton indotineae—New York City, December 2021–March 2023. MMWR Morb Mortal Wkly Rep. 2023;72(19):536‐537. doi:10.15585/mmwr.mm7219a4
Moseley I, Ragi SD, Ouellette S, Rao B. Tinea versicolour in underrepresented groups: an All of Us database analysis. Skin Health Dis. 2022;3(1):e152. doi:10.1002/ski2.152
Atsü N, Ergin Ç, Caf N, Türkoğlu Z, Döğen A, İlkit M. Effectiveness of FastFung agar in the isolation of Malassezia furfur from skin samples. Mycoses. 2022;65(7):704‐708. doi:10.1111/myc.13450
Bartell H, Ransdell BL, Ali A. Tinea versicolor clearance with oral isotretinoin therapy. J Drugs Dermatol. 2006;5(1):74‐75.
Ghosh SK, Dey SK, Saha I, Barbhuiya JN, Ghosh A, Roy AK. Pityriasis versicolor: a clinicomycological and epidemiological study from a tertiary care hospital. Indian J Dermatol. 2008;53(4):182‐185. doi:10.4103/0019-5154.44791
Al‐Jabre SHM, Al‐Sultan AI. Infectious dermatoses in adult diabetic patients. J Eur Acad Dermatol Venereol. 1995;5(3):264‐268. doi:10.1016/0926-9959(95)00087-0
Thailak S, Anbumalar M, Sneha PM. Cutaneous fungal infections in subjects with diabetes mellitus. Int J Res Dermatol. 2017;3(1):55‐58. doi:10.18203/issn.2455-4529.IntJResDermatol20164412
Mandel EH, Ores RO, Siragusa RJ. The incidence of diabetes mellitus in patients with tinea versicolor. J Natl Med Assoc. 1974;66(3):198‐200.
Mansour A, Hamdi K, Amer A‐A. Prevalence of Pityriasis versicolor among diabetics in Basrah. Arch Med Sci. 2008;4(4):443‐446.
Wahid Z, Nasreen S, Usman G, Ahmed I. Frequency of pityriasis versicolor in patients with uncontrolled type 2 diabetes attending a Tertiary Care Hospital. JLUHMS. 2013;12(1):3‐6.
Timshina DK, Thappa DM, Agrawal A. A clinical study of dermatoses in diabetes to establish its markers. Indian J Dermatol. 2012;57(1):20‐25. doi:10.4103/0019-5154.92671
Rao GS, Kuruvilla M, Kumar P, Vinod V. Clinico‐epidermiological studies on tinea versicolor. Indian J Dermatol Venereol Leprol. 2002;68(4):208‐209.
Pochi PE, Strauss JS, Downing DT. Age‐related changes in sebaceous gland activity. J Invest Dermatol. 1979;73(1):108‐111. doi:10.1111/1523-1747.ep12532792
Faergemann J, Fredriksson T. Tinea versicolor with regard to seborrheic dermatitis: an epidemiological investigation. Arch Dermatol. 1979;115(8):966‐968. doi:10.1001/archderm.1979.04010080030017
Rubenstein RM, Malerich SA. Malassezia (pityrosporum) folliculitis. J Clin Aesthet Dermatol. 2014;7(3):37‐41.
Mendez‐Tovar LJ. Pathogenesis of dermatophytosis and tinea versicolor. Clin Dermatol. 2010;28(2):185‐189. doi:10.1016/j.clindermatol.2009.12.015